Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study.
Lancet Reg Health West Pac
; 32: 100638, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36793753
ACLF, acute-on-chronic liver failure; AUROC, area under the receiver operating characteristic curve; Acute-on-chronic liver failure; CLIF-C ACLFs, CLIF-C ACLF score; CLIF-C, chronic liver failure Consortium; CLIF-OFs, CLIF-organ failure score; COSSH, Chinese Group on the Study of Severe Hepatitis B; COSSH-ACLF IIs, COSSH-ACLF II score; COSSH-ACLFs, COSSH-ACLF score; EASL, European Association for the Study of the Liver; HBV, hepatitis B virus; HE, hepatic encephalopathy; Hepatitis B virus; INR, international normalized ratio; LT, liver transplantation; Liver transplantation; MELD-Nas, MELD-sodium score; MELDs, Model for End-stage Liver Disease score; PSM, propensity score matching; Survival benefit; TB, total bilirubin; Transplant timing
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Lancet Reg Health West Pac
Year:
2023
Document type:
Article